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a  b  s  t  r  a  c  t
Zinc  oxide  (ZnO)  nanoparticles  have  been  widely  used  in  industry,  cosmetics,  and
biomedicine.  Recent  studies  suggested  that  these  nanoparticles  could  have  a  major  impact
on the  cardiovascular  system.  Endothelial  progenitor  cells  (EPCs)  contribute  to postnatal
endothelial  repair  and regeneration.  The  present  study  dissected  the effects  of  ZnO  nanopar-
ticles on vasculogenesis  using  human  endothelial  colony  forming  cells  (ECFCs),  which
participate  in  post-natal  vasculogenesis.  Two  types  of  ZnO  particles  were  used  (nano  and
micro),  in  addition  to zinc  chloride  solutions  with  zinc ion  concentrations  equal  to  those  in
ZnO nanoparticles.  Twenty-four-hour  exposure  induced  cytotoxicity  in  a dose-dependent
manner  and  increased  ECFCs  apoptosis  in  all groups.  The  exposure  also  reduced  the  func-
tional capacity  of  ECFCs  on  Matrix  gel  to  form  tubules,  compared  with  the  control  cells.
These  effects  were  associated  with  downregulation  of expression  of vascular  endothelialVEGFR2
CXCR4
growth  factor  receptor,  VEGFR2  and  CXC  chemokine  receptor,  CXCR4.  The  results  suggest
that ZnO  nanoparticles  suppress  vasculogenesis  from  ECFCs  through  downregulation  of  the
expression  of receptors  related  to vasculogenesis.  These  effects  are  based  the  concentration
of released  Zn(II).
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe  CC  BAbbreviations: CXCR4, CX chemokine receptor; ECFCs, endothelial
colony forming cells; EPCs, endothelial progenitor cells; ICP-AES, induc-
tively coupled plasma atomic emission spectrometry; PdI, polydispersity
index; VEGFR2, vascular endothelial growth factor A receptor 2; ZnCl2,
zinc chloride; ZnO, zinc oxide.
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1. Introduction
The recent explosive development in the ﬁeld of nano-
technology provides potentially promising applications
for manufactured nanomaterials in a variety of ﬁelds.
The rapidly developing ﬁeld of nanotechnology poten-
tially exposes human to engineered nanoparticles through
different routes, including inhalation (respiratory tract),
ingestion (gastrointestinal tract), dermal (skin), and injec-
tion (blood circulation) [1]. Therefore, the establishment of
a new discipline of nanotoxicology is needed to address the
new potential threats associated with the widespread use
is is an open access article under the CC BY-NC-ND license
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f new nanoparticles, which should provide support for any
urther growth of a safe and sustainable nanotechnology
ndustry, since nanoparticles could, at least theoreti-
ally, have adverse effects on the lungs and other organs
2].
The relative surface area of particles correlates with
he degree of their toxicity [3]. Furthermore, nanoparticles
an generate reactive oxygen species, resulting in induc-
ion of oxidative stress and inﬂammation [4,5]. Zinc oxide
ZnO) nanoparticles are among the most commonly used
anomaterials, and are widely used in paint, pharmaceu-
ical, and cosmetics industries, in addition to biomedicine.
ecent studies reported worrying harmful effects for ZnO
anoparticles; they have been demonstrated to increase
he expression of adhesion molecules in vascular endothe-
ial cells [6,7] and to induce inﬁltration of macrophages
nd lipid accumulation in the intimal and medial areas of
he arterial wall in an animal model [8]. Our group has
lso showed that ZnO nanoparticles increase macrophage
holesterol uptake [9]. Considered together, the new data
uggest that ZnO nanoparticles could potentially increase
he risk of cardiovascular diseases, including atherosclero-
is.
Endothelial progenitor cells (EPCs) are one subset of
rogenitor cells that originate in the bone-marrow and
re mobilized to the post-natal circulation. These cells
an differentiate into mature endothelial cells and home
o sites of tissue injury where they play an important
ole in facilitating vascular repair and tissue regenera-
ion [10]. Previous studies have demonstrated a clear link
etween reduced numbers and dysfunctionality of circu-
ating EPCs and increased cardiovascular risk [11]. Indeed,
PC dysfunction may  not only be a marker of cardiovas-
ular risk, but may  also represent a pathophysiologic link
etween cardiovascular risk factors and the development
f atherosclerosis [12]. Evidence based on epidemiological
nd toxicological studies indicates that high concentra-
ions of particle masses <2.5 m (PM2.5) are associated
ith high risk of cardiovascular events and death from
ardiovascular diseases [13,14]. The endothelium is a sen-
itive target of PM,  and animals and humans exposed
o PM show endothelial dysfunction [15] and EPC deple-
ion [16], suggesting that PM exposure can potentially
arm the endothelium by causing acute and direct loss of
ow-mediated dilation and attenuation of EPC-mediated
ndothelial repair and regeneration [17].
ZnO nanoparticles can potentially increase the inci-
ence of cardiovascular diseases, although the mecha-
ism(s) behind this relation remain unclear. Our working
ypothesis is that exposure to ZnO nanoparticles results
n functional impairments of EPCs. The present study
issected the effects of ZnO nanoparticles on endothe-
ial tubule formation, using an in vitro set-up of human
ndothelial colony forming progenitor cells (ECFCs). These
ells are commonly used in vascular regenerative medicine
nd regarded as a promising target for antiangiogenic
umor therapy due to their robust proliferative poten-
ial and profound vessel-forming capacity [18]. The study
lso determined the role of Zn(II) ion on EPCs function
sing ZnO nano- and micro-particles and zinc chloride
ZnCl2).eports 2 (2015) 692–701 693
2. Methods
2.1. Nanoparticle preparation and characterization
Nano-sized ZnO particles (ZnO-n1) (MKN-ZnO-020;
mkNano, Mississauga, ONT, Canada) and (ZnO-n2) (351-
34492; WAKO Pure Chemical Industries, Osaka, Japan)
with primary diameter of 20 nm,  micro-sized ZnO parti-
cles (ZnO-micro) (WAKO Pure Chemical Industries) with
primary diameter of 5 m,  and zinc chloride (ZnCl2)
(Sigma–Aldrich, St. Louis, MO)  were used in the present
study. We  previously characterized TiO2 and ZnO nanopar-
ticles from the same lot by not only dynamic light scattering
(DLS), but also transmission electron microscope (TEM),
and then established a suitable and reproducible proto-
col for the preparation of suspension of TiO2 and ZnO
nanoparticles [19]. As described in this paper, nanoparti-
cles were suspended in serum containing culture media
and dispersed using a sonicator (Branson Soniﬁer model
450, Danbury, CT, 80% pulsed mode, 100 W,  15 min). The
hydrodynamic size of the particles in media was measured
four times after 1 h on standing using DLS technology with
a Zetasizer Nano-S (Malvern Instruments, Worcestershire,
UK). Dispersion status was  described by the intensity-
weighted hydrodynamic average diameter (z-average) and
polydispersity index (PdI), which reﬂect the broadness of
the size distribution (scale range from 0 to 1, with 0 being
monodispersion and 1 being polydispersion).
2.2. Cell culture and cytotoxicity assay
Human circulating EPCs with in vitro clonogenic capac-
ity, also known as endothelial colony-forming cells (ECFCs),
obtained from Lonza Group (Basel, Switzerland), were cul-
tured in endothelial growth medium (EGM-2 BulletKit,
Lonza Group) at 37 ◦C in 5% CO2. The ECFCs were isolated
from the primary cord blood mononuclear cells. Cells were
passaged with trypsin-EDTA, trypsin neutralizing solution
and Hanks’ Balanced Salt Solution (HBSS) (Life Technolo-
gies, Carlsbad, CA) every 2–3 days and experiments were
performed using ECFCs between passages 6 and 8.
ECFCs were seeded overnight at 1.5 × 104 cells per well
on 96-well plates before the experiment. Particles were dis-
persed in serum containing cell culture medium, the ﬁnal
concentration of the particles ranged from 1 to 100 g/ml.
The concentration range is corresponding with the dose
used in previous studies using human aortic endothelial
cells (HAECs) [6] and human umbilical vein endothelial
cells (HUVECs) [9] exposed to ZnO nanoparticles. It was
assumed that Zn(II) concentration in 25 mg/ml  of ZnO
nanoparticles was  equal to that in 307 mM (41.8 mg/ml) of
ZnCl2 based on the data reported in a previous paper [20],
and calculated the concentration of ZnCl2 corresponding to
the nanoparticles. Cytotoxicity was  determined after incu-
bation of the dispersed ZnO particles or dissolved ZnCl2 for
24 h, by MTS  assay as indicated by the CellTiter 96 AQueous
One Solution (Promega, Madison, WI), which is a colori-
metric method for determining the number of viable cells.
The serum containing cell culture medium was  used dur-
ing incubation with the particles. After 24-h incubation, the
cells were incubated with fresh medium (phenol red-free)
icology R694 S. Tada-Oikawa et al. / Tox
containing MTS  reagent for 1 h before absorbance measure-
ments at 490 nm.  The effect of particles on cell proliferation
was calculated as percentage of inhibition of cell growth
relative to the control.
2.3. Inductively coupled plasma-atomic emission
spectroscopy (ICP-AES)
The stock suspensions were diluted to a ﬁnal volume
of 15 ml  EGM-2 complete to a ﬁnal concentration of 1, 10,
or 100 g/ml ZnO particles. In the same way, 1.67, 16.7,
or 167 g/ml ZnCl2 solution was prepared. Each sample
was incubated at 37 ◦C in 5% CO2 for 0, 1, 6, and 24 h.
After centrifugation for 20 min  at 10,000 × g, 10 ml  of the
supernatant was transferred into a test tube that contained
0.5 ml  of concentrated nitric acid (HNO3; Wako Pure Chem-
ical Industries). The solution was then subjected to zinc
analysis by inductively coupled plasma atomic emission
spectrometry (ICP-AES), as described previously [21]. The
residual 5 ml  containing the precipitate (ZnO nanoparti-
cles that were left in dispersion medium) was acidiﬁed
with 0.5 ml  of concentrated nitric acid, transferred into a
tube and treated with 60% perchloric acid until all contents
were dissolved. The resulting solution was ﬁlled up to 50 ml
with water and analyzed for zinc contents using ICPS-7500
(Shimadzu, Kyoto, Japan).
2.4. Tubule formation assay
ECFCs (5.0 × 104 cells) were placed in 24-well plates
pre-coated with solidiﬁed Matrigel Matrix (BD Biosciences,
San Jose, CA) and exposed to different doses (10 or
25 g/ml) of the dispersed ZnO particles or dissolved 16.7
or 41.8 g/ml ZnCl2 for 24 h at 37 ◦C. The cells were stained
with CalceinAM (BD Biosciences) and tubule formation was
examined under a ﬂuorescence microscope (×40) (model
FSX100, Olympus, Tokyo), as described previously [22].
Six representative ﬁelds were selected and the length or
area of complete tubes formed by cells was measured by
a computer digital imaging software (CellSens Software,
Olympus).
2.5. Apoptosis assay
ECFCs were seeded overnight at 2.0 × 105 cells per well
on 24-well plates before the experiment. After incubation
with the dispersed ZnO particles or dissolved ZnCl2 for
24 h, the cells were harvested with EDTA-trypsin, washed
twice with PBS, and stained with ﬂuorescein isothio-
cyanate (FITC)–annexin V and propidium iodide using TACS
Annexin V apoptosis detection kit (Trevigen, Gaithersburg,
MD). The labeled cells were analyzed by ﬂow cytometry
(FACS Canto II, BD Biosciences). The ﬂuorescent signal was
detected through the FITC channel with at least 10,000
events acquired for each sample.
2.6. RNA isolation and analysis of RT-PCRECFCs (2.0 × 105 cells) were grown overnight in 12-well
plates at 37 ◦C, and then exposed to 25 g/ml of the dis-
persed ZnO particles or dissolved ZnCl2 for 1, 3, or 6 heports 2 (2015) 692–701
at 37 ◦C. Total RNA from the cells was isolated by using
ReliaPrep RNA cell miniprep system (Promega) using the
protocol provided by the manufacturer. The concentration
of total RNA was  quantiﬁed by spectrophotometry (ND-
1000; NanoDrop Technologies, Wilmington, DE). RNA was
reverse transcribed to single-strand cDNA using Super-
Script III First-Strand Synthesis System for RT-PCR (Life
Technologies). cDNA (n = 4 in each group) was subjected
to quantitative PCR analysis with FastStart Universal Probe
Master Mix  (Roche, Basel, Switzerland) using primers for
human vascular endothelial growth factor A receptor 2,
VEGFR2, CX chemokine receptor, CXCR4, and phosphatase
and tensin homolog deleted on chromosome 10, PTEN,
using an ABI 7000 Real-Time PCR system (Life Technolo-
gies), as described previously [23]. The gene expression
level was normalized to that of -actin in the same cDNA.
2.7. Statistical analysis
All parameters were expressed as mean ± standard
deviation (SD). Statistical analyses were performed using
one-way analysis of variance (ANOVA) followed by Dun-
nett’s post hoc test. A p value less than 0.05 was  considered
statistically signiﬁcant.
3. Results
3.1. Characterization of nanoparticles in suspension
Both nano-sized ZnO particles were dispersed in the
culture medium of ECFCs. The intensity-weighted hydro-
dynamic mean diameter of the dispersed nanoparticles
was  measured by DLS technology. Table 1 shows the mean
hydrodynamic diameter and PdI of dispersed ZnO nanopar-
ticles in the medium. The analysis software of DLS provided
the value for the size distribution based on number and
volume of particles. Based on the observed dispersion,
the presence of nano-sized particles was conﬁrmed in
the medium (Fig. 1); the number of particles measur-
ing less than 100 nm was 83.4 ± 2.3% and 78.7 ± 1.5%
and the volume of particles measuring less than 100 nm
was  43.2 ± 1.7% and 42.7 ± 1.7%, for ZnO-n1 and ZnO-
n2 nanoparticles, respectively. Both ZnO-n1 and ZnO-n2
nanoparticles were dispersed to a similar extent.
3.2. Amount of zinc analyzed by ICP-AES
ICP-AES was  used to analyze the amount of zinc in the
supernatant and precipitate of the dispersed ZnO particles
and dissolved ZnCl2 solution. The total amount of zinc was
almost the same in the dispersed 1 or 10 g/ml of ZnO-n1
and ZnO-micro particles and the corresponding concen-
tration (1.67 or 16.7 g/ml) of ZnCl2 solution (Fig. 2). The
results also demonstrated that the total amount of zinc was
almost the same in the solutions of dispersed 100 g/ml
of ZnO-n1 nanoparticles and the corresponding concentra-
tion of ZnCl2 (167 g/ml). The amount of zinc was lower
in the solution of 100 g/ml of ZnO-micro particles than
in the solution of dispersed 100 g/ml of ZnO-n1 nanopar-
ticles. However, since zinc amount was  not measured as
S. Tada-Oikawa et al. / Toxicology Reports 2 (2015) 692–701 695
Table  1
Characterization of nano-sized ZnO particles.
Particles Primary diameter (nm) Medium Hydrodynamic size (nm) PdI
ZnO-n1 20 EGM-2 (12% FBS) 116.7 ± 1.3 0.282 ± 0.006
ZnO-n2 20 EBM-2 (12% FBS) 116.6 ± 0.7 0.171 ± 0.007
Data are mean ± SD of four independent experiments.
PdI: polydispersity index, EGM: endothelial growth medium, FBS: fetal bovine serum.
Fig. 1. Histogram of particle size distribution measured by dynamic light scatte
were  dispersed using a sonicator at 100 W,  80% pulse mode, for 15 min.
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Fig. 2. Zinc ion content in the supernatant and precipitate of solutions
dispersed ZnO particles or dissolved ZnCl2. Results are ICP-AES measure-
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tents of supernatants and precipitates of 1, 10, 100 g/ml of ZnO-n1
anoparticles, ZnO-micro particle, and dissolved ZnCl2 at the correspond-
ng concentrations for 1, 6, and 24 h.
ppropriate replicates in the present study, there may be no
bility to comment on variability or perceived differences..3. Cytotoxicity
ECFCs were exposed for 24 h to the dispersed ZnO par-
icles at a concentration ranging from 1 to 100 g/ml andring technology. (A) ZnO-n1 and (B) ZnO-n2 nanoparticles suspensions
dissolved ZnCl2 at the corresponding concentrations. The
MTS  assay showed that incubation of ECFCs in the presence
of nano- and micro-sized ZnO particles at 50–100 g/ml
signiﬁcantly induced cytotoxicity (Fig. 3A–C). Cytotoxic-
ity was also signiﬁcantly induced after exposure to the
corresponding concentration of 50 or 100 g/ml (83.7 or
167 g/ml) of ZnCl2 (Fig. 3D). The MTS  assay showed
that incubation of ECFCs in the presence of ZnO particles
at more than 30 g/ml signiﬁcantly induced cytotoxicity
(Fig. 3E). Therefore, we used particle concentrations of 10
and 25 g/ml and the corresponding concentration (16.7
or 41.8 g/ml) of ZnCl2 to analyze tube formation.
3.4. Effects of ZnO particles on tubule formation
To determine the effects of dispersed ZnO particles and
dissolved ZnCl2 on angiogenesis, we evaluated their effects
on tubule formation. Under control conditions, ECFCs cells
formed a well organized tubule network (Fig. 4A(a)). How-
ever, exposure of ECFCs to the dispersed ZnO particles and
dissolved ZnCl2 resulted in marked disruption of the tubule
network (Fig. 4A(b)–(e)). The tubule length was  signiﬁ-
cantly lower in ECFCs exposed to 10 or 25 g/ml of ZnO-n1
and ZnO-n2 nanoparticles and ZnO-micro particles, and the
corresponding concentration (16.7 or 41.8 g/ml) of ZnCl2
than in the control (Fig. 4B). Furthermore, the tubule area
696 S. Tada-Oikawa et al. / Toxicology Reports 2 (2015) 692–701
Fig. 3. Effects of dispersed ZnO particles and dissolved ZnCl2 on cytotoxicity. Cytotoxicity was  measured by MTS  assay. ECFCs were exposed to (A) ZnO-n1
s rangi
 for 24 h
and  (B) ZnO-n2 nanoparticles and (C) ZnO-micro particle at concentration
167  g/ml, and (E) ZnO particles at the concentration of 30 and 40 g/ml
was signiﬁcantly lower in ECFCs exposed to 25 g/ml of
ZnO-n1 and ZnO-n2 nanoparticles and ZnO-micro parti-
cle and the corresponding concentration (41.8 g/ml) of
ZnCl2 than in the control (Fig. 4C). The tubule area was
signiﬁcantly smaller even after exposure to 16.7 g/ml of
ZnCl2. Quantiﬁcation of tubule formation conﬁrmed the
microscopic observation on the effects of the dispersed ZnO
particles and dissolved ZnCl2 exposure on angiogenesis.ng from 1 to 100 g/ml, (D) ZnCl2 at concentrations ranging from 1.67 to
. Data are mean ± SD of six replicates. *p < 0.05 vs. control (0 g/ml).
3.5. Effects of ZnO particles on apoptosis
Annexin V staining of ECFCs (annexin-V positive
and propidium-iodide negative/annexin-V positive and
propidium-iodide positive) demonstrated apoptosis of a
proportion of cells among the adherent cells at 24 h after
exposure to 50 and 100 g/ml of ZnO-micro particles and
the corresponding concentration of ZnCl2 (Fig. 5). The fold
S. Tada-Oikawa et al. / Toxicology Reports 2 (2015) 692–701 697
Fig. 4. Tubule formation assay of ECFCs. (A) Representative images of tubule formation from ECFCs exposed to 25 g/ml of ZnO particles or the corresponding
concentration of ZnCl2 for 24 h. Scale bar = 200 m.  (B) Tubule length and (C) tubule area from ECFCs exposed to 10 or 25 g/ml of the dispersed ZnO particles
and  corresponding concentrations of dissolved ZnCl2. Six representative ﬁelds we
formed was  measured by a computer digital imaging software. Data are mean ± SD
*p  < 0.05 vs. control (0 g/ml).
Fig. 5. Effects of ZnO on apoptosis of ECFCs assessed by ﬂow cytome-
try.  ECFCs were exposed to ZnO-n1, ZnO-n2 nanoparticles and ZnO-micro
particle at concentrations ranging from 1 to 100 g/ml, or to ZnCl2 at the
indicated concentrations for 24 h. Data are mean ± SD of four replicates.
*p < 0.05 vs. control (0 g/ml).re selected in each culture well and the length or area of complete tubes
 from minimum three cell culture wells of 1–3 independent experiments.
increase in this population of annexin-V positive apoptotic
cells was  especially signiﬁcant after exposure of ECFCs to
16.7 g/ml of ZnO-n2 nanoparticles, compared with the
control (Fig. 5). The effects of ZnCl2 were much more pro-
nounced as compared to the other groups in particular at
the concentration of 50 and 100 g/ml.
3.6. Effects of ZnO particles on VEGFR2 and CXCR4
expression
The expression level of VEGFR2 mRNA was signiﬁ-
cantly lower in ECFCs exposed to 25 g/ml of ZnO particles
and the corresponding concentration of ZnCl2 for 6 h than
in the control (Fig. 6A(c)). There was no signiﬁcant dif-
ference in the mRNA expression level in ECFCs exposed
to the dispersed ZnO particles or dissolved ZnCl2 for 1
or 3 h only (Fig. 6A(a) and (b)). The expression level of
CXCR4 mRNA was signiﬁcantly lower in ECFCs exposed to
25 g/ml of ZnO particles or the corresponding concentra-
tion of ZnCl2 for 3 or 6 h than in the control (Fig. 6B(b)
698 S. Tada-Oikawa et al. / Toxicology Reports 2 (2015) 692–701
sion lev
d the co
l).Fig. 6. Effects of dispersed ZnO particles or dissolved ZnCl2 on the expres
CXCR4 mRNA in ECFCs exposed to 25 g/ml of dispersed ZnO particles an
Data  are mean ± SD of three or four replicates. *p < 0.05 vs. control (0 g/m
and (c)). The change in CXCR4 mRNA level was observed
in ECFCs exposed to ZnO-n2 and ZnO-micro particles from
1 h after exposure (Fig. 6A(a)). Exposure to ZnO particles
or ZnCl2 did not affect the expression level of PTEN mRNA
(data not shown).
4. DiscussionThe present study demonstrated that in vitro exposure
of ECFCs to ZnO nanoparticles attenuated tubule formation.
Since exposure to ZnO micro-sized particles or dissolved
ZnCl2 had similar effects, these changes are considered toels of membrane type receptors. Expression levels of (A) VEGFR2 and (B)
rresponding concentration of dissolved ZnCl2 for (a) 1 h, (b) 3 h, or (c) 6 h.
be based on the concentration of the released Zn(II). We
also demonstrated that in vitro exposure of ECFCs to dis-
persed ZnO particles and dissolved ZnCl2 suppressed the
expression of the membrane type receptors involved in
vasculogenesis.
Previous studies suggested that inhaled particles in the
lungs may  cause systemic inﬂammation through oxidative
stress, which also mediates endothelial dysfunction [24].
Several studies demonstrated that nano-sized particles
can cross the pulmonary epithelial barrier and enter the
bloodstream [25,26], although translocation of nanopar-
ticles from the lung into the circulation was  slow and
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ery low [27]. The results of animal studies on alveolar
ranslocation of nanoparticles suggest the existence of the
ame pathway in humans; however, the extent of extra-
ulmonary translocation is highly dependent on particle
urface characteristics/chemistry, as well as particle size
28]. In addition to the lungs, several types of nanoparti-
les have been reported to translocate and accumulate in
he bone marrow after administration to animals [29,30].
hese results suggest that nanoparticles could be taken up
y bone marrow-derived mononuclear cells and provide a
echanism for the direct effects on such cells. Therefore,
e focused in the present study on the direct effects of ZnO
anoparticles on cultured EPCs in order to explore the cel-
ular mechanisms responsible for the cardiovascular effects
f nanoparticles.
EPCs differentiate into mature endothelial cells and play
n important role in facilitating vascular repair and tis-
ue regeneration [10]. Previous studies demonstrated that
he numbers and functionality of EPCs may  predict the
linical outcome and prognosis of cardiovascular diseases
31,32]. Previous studies showed that exposure to PM was
ssociated with a decrease in the number of EPCs [16,17].
oreover, diesel exhaust particles impaired neoangiogen-
sis due to a reduction in the number of circulating EPCs
nd a signiﬁcant increase in apoptosis of EPCs [33]. Chronic
xposure to tobacco smoke is not only associated with low
PC levels [34] but also impaired EPC functional activities
e.g., chemotaxis, migration, and adhesion) [35]. Thus, vari-
us species and sizes of particles can impair the function of
PCs. In the present study, incubation of ECFCs in the pres-
nce of nano- and micro-sized ZnO particles at the high
oncentrations (50–100 g/ml) signiﬁcantly induced cyto-
oxicity. To conﬁrm if the effects are speciﬁcally related to
n(II), we need further studies exposing to other metal-
ontaining nanoparticles at the same condition.
Metal oxide nanoparticles are newly developed mate-
ials used in a variety of applications. Nano-sized ZnO
nd TiO2 have been applied extensively in different ﬁelds,
ncluding industry, cosmetics, and biomedicines. It has
een reported that ZnO particles induce inﬂammatory
esponses and adhesion molecules in endothelial cells
n a dose-dependent manner [6,8]. We  have also shown
ecently that ZnO nanoparticle can potentially enhance
HP-1 monocyte cell migration, adhesion of THP-1 cells to
uman umbilical vein endothelial cells and uptake modi-
ed LDL by THP-1 macrophages in vitro [9]. In the present
tudy, the functional capacity of ECFCs for tubule forma-
ion on Matrix gel was reduced in cells exposed to 10 or
5 g/ml of ZnO nanoparticles compared with the control
ells. Our ﬁndings are in agreement with those of previ-
us studies, which reported that exposure to inhaled nickel
anoparticles resulted in dysfunction of bone-marrow EPC
36].
Hammond [37] reported that workers exposed to
nO nanoparticle at concentrations of approximately
25 mg/m3 for 3 h have experienced metal fume fever.
n a previous in vitro study [38], ZnO nanoparticles were
xposed to primary cultured rat alveolar epithelial cell
onolayers at the concentration from 11 to 176 g/ml,
ased on an assumption that ZnO deposited in the lung
ould be 8.8 g/cm2 if the workers are exposed to ZnOeports 2 (2015) 692–701 699
nanoparticles at 725 mg/m3 for 24 h, with a respira-
tory minute volume of 20 l/min, ∼70 m2 surface area of
airspaces of the lung, and 30% of inhaled ZnO deposition
in the lung. Previous studies have reported that approx-
imately 10–15% of inhaled nanoparticles translocate into
the blood vessels [39]. In the present study, the functional
capacity of ECFCs for tubule formation was  reduced in cells
exposed to ZnO nanoparticles at 10 or 25 g/ml, which are
comparable to 3.9 or 9.9 g/cm2, respectively. Although
this value is relatively high, but the results suggest that the
concentrations adopted in the present study are relevant
to ZnO concentrations that can suppress vasculogenesis in
human EPCs.
In the present study, the functional capacity of ECFCs
for tubule formation was  reduced to the same extent in
cells exposed to either the ZnO-micro particles or dis-
solved ZnCl2. These results are consistent with previous
studies demonstrating that dissolved zinc ions seem to
mediate the toxic effects of ZnO particles [40]. On the
other hand, a recent study suggested other factors play
an important role in the toxic effects of ZnO nanoparti-
cles based on the ﬁnding of negligible toxic contribution
of released Zn(II) ions in A549 cell lines [41]. Moreover,
another study demonstrated that rapid, pH-dependent dis-
solution of ZnO nanoparticles inside the phagosomes is
the main cause of ZnO nanoparticles-induced tissue injury
[42] and that soluble intracellular Zn(II) ions, rather than
soluble extracellular Zn(II) ions, are key components in
modulating the bioactivity of ZnO nanoparticles [43]. In the
present study, our results indicated that dissolved Zn(II)
ions in the culture medium impaired tubule formation in
EPCs exposed to ZnO nanoparticles; consistent with the
previous studies that demonstrated that ZnO nanoparti-
cles toxicity is largely due to the release of toxic Zn(II) ions
which occurs predominantly in extracellular compartment
in the culture medium [20]. We  previously demonstrated
a signiﬁcant correlation between the amount of metal
uptaken by HUVECs and the concentration of ZnO particles
in the medium, as determined by ICP-Mass Spectrome-
try, and showed increase in free intracellular zinc ions in
HUVECs exposed to ZnO particles by measuring a zinc-
speciﬁc ﬂuorescent (zinquin ethyl ester) [9]. We believe
that intracellular Zn-content increases with increasing
exposure concentration of ZnO particles in the ECFCs cul-
ture medium, although the intracellular Zn-content was
not measured in the present study. To demonstrate the
importance of intracellular Zn(II) ions for the bioactiv-
ity or toxic effects of ZnO nanoparticles, we need to
compare the intracellular Zn concentrations between the
groups.
In the present study, exposure of ECFCs to either dis-
persed ZnO particles or dissolved ZnCl2 resulted in a
signiﬁcant increase in apoptosis, compared with the con-
trol. The effects of ZnCl2 were much more pronounced
as compared to the other groups in particular at concen-
trations of 50 and 100 g/ml. The amount of zinc in the
solution of 100 g/ml of ZnO-micro particles was lower
than those in the solution of the corresponding concentra-
tion of ZnCl2 (167 g/ml) although the amount of zinc in
the solutions of ZnO nanoparticles was  almost the same as
the corresponding concentration of ZnCl2. The difference in
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the results of the apoptosis assay may  reﬂect the difference
in the concentration of intracellular Zn(II) ions resulting
from exposures to ZnO particles and ZnCl2. Apoptosis is
an important process during normal development as it
contributes to the maintenance of tissue homeostasis. Sev-
eral studies have indicated that endothelial cell apoptosis
is closely involved in vascular growth and vessel regres-
sion and limitation of angiogenesis [44]. Previous studies
showed that exposure to ZnO nanoparticles induced apo-
ptosis of macrophages [45,46]. Although EPCs are less
sensitive to apoptosis compared with mature endothelial
cells [47], apoptosis is an important regulatory cellular
mechanism under pathophysiological conditions involving
EPCs. Since induction of apoptosis is a key element in the
regulation of EPC numbers and function [48], our results
suggest that it represents one of the mechanisms of the
observed anti-proliferative effects of dispersed ZnO parti-
cles and dissolved ZnCl2 on ECFCs.
Vascular endothelial growth factor (VEGF) and its recep-
tor, VEGFR2, and chemokine stromal cell-derived factor-1
(SDF-1) and its receptor, CXCR4 signal pathway, play
key roles in mobilization and development of vascular
networks [49]. Indeed, increased expression of these recep-
tors has been described to result in increased EPCs homing
to the ischemic zone and that it is a suitable therapeutic tar-
get in angiogenesis after myocardial infarction [50,51]. In
the present study, exposure of ECFCs to ZnO nanoparticles
signiﬁcantly decreased the expression levels of VEGFR2
and CXCR4 in all groups. These results suggest that the
exposure-induced reduction of functional capacity of ECFCs
for tubule formation was due to the down-regulation of
membrane type receptors related to vasculogenesis. This
ﬁnding is in agreement with a previous study, which
showed signiﬁcant correlation between CXCR4 expression
level and in vitro angiogenic function as well as ability to
promote angiogenesis and repair of vascular injury in vivo
[52].
5. Conclusion
The present study demonstrated that exposure of ECFCs
to ZnO nanoparticles attenuated vasculogenesis and this
effect was probably related to the concentration of released
Zn(II) in the culture medium. We  also demonstrated that
Zn(II) released from the dispersed ZnO particles and dis-
solved ZnCl2 suppressed the expression of membrane type
receptors related to vasculogenesis.
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